Human medicines European public assessment report (EPAR): Tyruko, natalizumab, Date of authorisation: 22/09/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Trixeo Aerosphere, formoterol,glycopyrronium bromide,budesonide, Date of authorisation: 09/12/2020, Revision: 7, Status: Authorised

CHMP PROM minutes for the meeting on 14 April 2025

Records of data processing activity for mail management

Minutes of the PRAC meeting 2-5 June 2025

QRD PSUR annex IV template

HCPWP plenary meeting September 2025, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2025, 14:00 (CEST) to 23 September 2025, 17:30 (CEST)

Moventig

PCWP/HCPWP joint meeting September 2025, European Medicines Agency, Amsterdam, the Netherlands, from 24 September 2025, 09:00 (CEST) to 24 September 2025, 16:10 (CEST)